Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)

CUSIP: G8807B106

Q1 2017 13F Holders as of 31 Mar 2017

Holder snapshot 7 signals
Share change
+4,446,910
Put/Call ratio
126%
SEC-reported price per share
$36.82
Number of holders
90
Value change
+$168,197,871
Number of buys
41
Open additional details 1 more signal available
Number of sells
40
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
51,428,000

Security key

G8807B106

Report period

Q1 2017

Institutions

90

Top holders

10

Ownership snapshot

Top reported holders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Woodford Investment Manag...
Disclosed value leader
Woodford Investment Manag...
Comparable rows
15/15
Latest evidence
31 Dec 2016
13F Lead comparable stake: 20% Showing 1-6 of 15 holder rows.

Quick read

Woodford Investment Management Ltd leads the comparable SEC ownership view at 20%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Woodford Investment Management Ltd's linked filing trail.
Comparable ownership Top 5
Woodford Investment Management Ltd 20%
BAUPOST GROUP LLC/MA 18%
FMR LLC 11%
VANGUARD GROUP INC 5.7%
BlackRock Fund Advisors 4.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Woodford Investment Management Ltd
13F
Company
13F
20%
$334,983,000
10,507,608 shares
31 Dec 2016
BAUPOST GROUP LLC/MA
13F
Company
13F
18%
$295,655,000
9,273,991 shares
31 Dec 2016
FMR LLC
13F
Company
13F
11%
$177,496,000
5,567,636 shares
31 Dec 2016
VANGUARD GROUP INC
13F
Company
13F
5.7%
$94,208,000
2,955,073 shares
31 Dec 2016
BlackRock Fund Advisors
13F
Company
13F
4.3%
$70,815,000
2,221,302 shares
31 Dec 2016
FIRST MANHATTAN CO. LLC.
13F
Company
13F
3.6%
$58,705,000
1,841,455 shares
31 Dec 2016
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
90
Shares
45,113,403
Rows available
90
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2017 vs Q4 2016 Across Filers

Q4 2016 holders
96
Q1 2017 holders
90
Holder diff
-6
Investor Q4 2016 Shares Q1 2017 Shares Share Diff Share Chg % Q4 2016 value Q1 2017 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .